Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
KHTRF
Primary Symbol:
T.GUD
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 07, 2024 7:30am
New Press Release - Knight Therapeutics Reports Third Quarter 2024
MONTREAL, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2024. All currency amounts are in thousands...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 31, 2024 7:30am
New Press Release - Notice of Knight Therapeutics' Third Quarter 2024 Results Conference Call
MONTREAL, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its third quarter 2024 financial results on Thursday, November 7, 2024, prior to market opening. Following the release, Knight...
read article.
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Oct 30, 2024 6:59am
RE:The gift that keeps on giving
...and what ebb and no flows did not comment on is that GUD has not made a dime in profits and the ammount of cash keeps declining every year. Ten years ago GUD had close to one billion dolalrs in
...more
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Post by
EbbFlow88
on Oct 29, 2024 12:58pm
The gift that keeps on giving
It's amazing that GUD is still trading in the 5's. Since GBT purchase in 2020.... Sales have gone from 200M to 350M Shares outstanding have gone from 140M to 100M Gross Margin from 41% to
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 15, 2024 8:30am
New Press Release - Knight Therapeutics Announces Approval of Minjuvi® (tafasitamab) in Mexico
MONTREAL, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V. has obtained regulatory approval by COFEPRIS, the Mexican...
read article.
(8)
•••
wofats
X
View Profile
View Bullboard History
Comment by
wofats
on Oct 11, 2024 1:36pm
RE:RE:RE:RE:People, Gud, has a lot of money and his value is around 10$
Just poking the bear. How do you explain something like this ? There is some monies to be made isn't there? Filed 2024-09-21 18:37 Tx date 2024
...more
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Oct 10, 2024 8:59am
RE:New redemption
Looks like they've slowed down the buybacks recently. I noticed at the beginning of October that they were buying back shares again in the first couple of days in a big way and then nothing since.
...more
(8)
•••
wofats
X
View Profile
View Bullboard History
Post by
wofats
on Oct 09, 2024 5:33pm
New redemption
Date Issuer Insider Transaction Amount New Balance Recent filings Filed 2024-10-09 13:54 Tx
...more
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Comment by
GoldenInvestor
on Sep 30, 2024 10:21am
RE:Adam Parker thoughts on healthcare strength
On CNBC this am
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Sep 30, 2024 10:21am
Adam Parker thoughts on healthcare strength
Healthcare - adam parker trivariate nbc excited by things w pricing power in economy, ie healthcare Services, hospitals & distributors as they will benefit from productivity
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 27, 2024 10:23am
New Press Release - Knight Therapeutics Inc. places No. 397 on The Globe and Mail's sixth annual ranking of Canada's Top Growing Companies
MONTREAL, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) (“Knight” or “the Company”) is pleased to announce it has ranked No. 397 on the 2024 Report on Business magazine’s ranking of Canada’s Top Growing Companies. Canada’s Top Growing Companies ranks Canadian companies...
read article.
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Sep 23, 2024 6:59am
RE:RE:RE:People, Gud, has a lot of money and his value is around 10$
I tell the truth with numbers and historical facts. Investors, if any ,on this foum can make up their own mind. and loose fortunes with GUD as many other have done including the major shareldors and
...more
(182)
•••
sylvain_007
X
View Profile
View Bullboard History
Comment by
sylvain_007
on Sep 21, 2024 8:55am
RE:RE:People, Gud, has a lot of money and his value is around 10$
Are you a basher, tell us why you wrote that and we will know why you did it. Are you an old shareholder if you're one, tell us why you are posting here if you are not an active shareholder. May
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Sep 20, 2024 9:19pm
RE:People, Gud, has a lot of money and his value is around 10$
Buy it and you will wait for years and nothing will happen as many investors have come and gone. Until MNGT is gone investors will not come back
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >